TILs and Anti-PD1 Therapy: An Alternative Combination Therapy for PDL1 Negative Metastatic Cervical Cancer

BACKGROUND: We investigated the efficacy of TILs and anti-PD1 combination therapy in patients with metastatic cervical cancer with low MSI expression and PDL1-negative. METHODS: A total of 80 patients were put on TILs and anti-PD1 combination therapy, and the progression-free survival time (PFS) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Huanhuan, Guo, Wei, Sun, Xiangling, Li, Ruili, Feng, Cuihua, Tan, Yujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492938/
https://www.ncbi.nlm.nih.gov/pubmed/32964058
http://dx.doi.org/10.1155/2020/8345235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492938/
https://www.ncbi.nlm.nih.gov/pubmed/32964058
http://dx.doi.org/10.1155/2020/8345235

Ejemplares similares